Join us for an insightful podcast exploring the latest milestones in the understanding and treatment of IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). Discover how recent breakthroughs in our understanding of these conditions are advancing clinical research and potential treatment opportunities. The conversation will also delve into the evolving role of dual angiotensin/endothelin receptor antagonism for these conditions, highlighting the results from recent clinical trials and their impact on patient care. Don’t miss this opportunity to stay at the forefront of innovation in nephrology care.

Sponsored by Travere Therapeutics